Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis
Authors
Keywords
IL-27, Hepatic cells, CXCR3 ligands, IFNγ, Liver inflammation
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 93, Issue 12, Pages 1355-1367
Publisher
Springer Nature
Online
2015-07-22
DOI
10.1007/s00109-015-1319-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Chemokine Receptor CXCR3 Is Degraded following Internalization and Is Replenished at the Cell Surface by De Novo Synthesis of Receptor
- (2014) A. Meiser et al. JOURNAL OF IMMUNOLOGY
- Protection and pathology during parasite infection: IL-10 strikes the balance
- (2014) S. A. Redpath et al. PARASITE IMMUNOLOGY
- IL-27, a Cytokine, and IFN- 1, a Type III IFN, Are Coordinated To Regulate Virus Replication through Type I IFN
- (2013) Y. Cao et al. JOURNAL OF IMMUNOLOGY
- Critical Role of Dendritic Cell-Derived IL-27 in Antitumor Immunity through Regulating the Recruitment and Activation of NK and NKT Cells
- (2013) J. Wei et al. JOURNAL OF IMMUNOLOGY
- High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV
- (2013) Geng-Lin Zhang et al. LIVER INTERNATIONAL
- TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis
- (2012) Muhammad Imran Arshad et al. HEPATOLOGY
- High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+T cells
- (2012) Song Zhang et al. HEPATOLOGY
- The Cytokines Interleukin 27 and Interferon-γ Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology
- (2012) Aisling O’Hara Hall et al. IMMUNITY
- Interleukin-27: Balancing Protective and Pathological Immunity
- (2012) Christopher A. Hunter et al. IMMUNITY
- NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis
- (2011) Muhammad I. Arshad et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury
- (2011) Denada Dibra et al. HEPATOLOGY
- CXCR3 Deficiency Exacerbates Liver Disease and Abrogates Tolerance in a Mouse Model of Immune-Mediated Hepatitis
- (2011) A. Erhardt et al. JOURNAL OF IMMUNOLOGY
- IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants
- (2010) F. Rousseau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-27 displays interferon-γ-like functions in human hepatoma cells and hepatocytes
- (2009) Herdis Bender et al. HEPATOLOGY
- CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver
- (2009) Katia Bourd-Boittin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
- (2009) R. Salcedo et al. JOURNAL OF IMMUNOLOGY
- Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
- (2009) Peng Hu et al. MOLECULAR IMMUNOLOGY
- Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro
- (2008) Chengliang Zhu et al. CLINICAL IMMUNOLOGY
- Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C
- (2008) Marija Zeremski et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started